Wave Life Sciences.
biotechnology company
- Reports this week
- 1
- Active events
- 1
- Connections
- 41
What's happening
Active this week
Earlier this month
-
Secondary offerings prompted huge insider buying involving Kymera Therapeutics and Wave Life Sciences.Some support1 report
-
Wave Life Sciences established its company headquarters in Cambridge, Massachusetts.Some support5 reports
-
Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Some support1 report
-
Wave Life Sciences is developing WVE-007, an investigational GalNAc-siRNA product, for MASH indications.Some support2 reports
One to three months ago
Gone quiet
No new reports in 90+ days-
Wave Life Sciences is seeking the accelerated approval pathway from the FDA ahead of mid-2026 feedback.Some support2 reports
-
H.C. Wainwright reaffirmed a buy rating on Wave Life Sciences, which also presented preclinical evidence at an ADA meeting in Chicago.Speculative1 report
-
Both CRISPR Therapeutics and Wave Life Sciences operate within the medical/biomedical industry.Some support1 report
-
Wave Life Sciences presented preclinical data at ADA Scientific Sessions on July 15, 2025.Some support3 reports
-
Wave Life Sciences delivered positive data from the N531 trial, with future milestones and payments remaining uncertain.Some support2 reports
-
Wave Life Sciences, based in Singapore, is developing therapies for DMD and targeting Huntington’s disease.Some support1 report
-
Wells Fargo lowered its price target on September 5, 2025, following trial results related to Wave Life Sciences.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Wave Life Sciences this week
News at the entities that move Wave Life Sciences most-
Nasdaq StructuralIPO filings are subject to SEC oversight, involving the Nasdaq stock exchange and the SEC.Moves Wave Life Sciences
-
Delaware StructuralThe DuPont family supports various causes from a base located in Delaware.Moves Wave Life Sciences
-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Wave Life Sciences
-
Mizuho TransactionalJefferies Financial Group upgraded its rating on Macerich, while Mizuho also increased its price objective for the company's stock.Moves Wave Life Sciences
-
Truist Financial Mentioned togetherTruist Financial, U.S. Bancorp, and Citigroup are reported as top holdings in various regional and financial sector ETFs.Moves Wave Life Sciences
-
Chicago Shared contextSteve Miller joined Chicago's international scouting department on October 21, 2026.Moves Wave Life Sciences
Connections
The 15 strongest of 41, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Wave Life Sciences is formally listed and trades on the Nasdaq stock exchange.
-
Delaware Structural
Wave Life Sciences has redomiciled its corporate operations to operate under the laws of the State of Delaware.
-
FDA Structural
Wave Life Sciences is seeking accelerated approval pathway from the FDA.
-
Christopher Wright Structural
Christopher Wright holds the position of Chief Medical Officer at Wave Life Sciences.
-
Mizuho Transactional
Mizuho issued a price objective assessment regarding Wave Life Sciences.
-
Arun J. Sanyal Mentioned together
Arun J. Sanyal provided expert perspective on RNA editing approaches relevant to Wave Life Sciences' field.
-
Chicago Shared context
Wave Life Sciences presented preclinical data and sessions at events held in Chicago.
-
Singapore Shared context
Wave Life Sciences was previously based in Singapore but is currently seeking redomiciliation from the jurisdiction.
Show all 15 connections
-
mash Mentioned together
Wave Life Sciences is involved in clinical trials that evaluate indications, including MASH.
-
Regeneron Pharmaceuticals Mentioned together
The two healthcare companies are mentioned in the same context as peers being compared.
-
Truist Financial Mentioned together
Truist Financial has initiated financial coverage and monitoring of Wave Life Sciences.
-
Eli Lilly and Company Mentioned together
Both companies are mentioned as part of the drugmaker industry observing IPO market activity.
-
New York City Shared context
Wave Life Sciences participates in conferences held within New York City.
-
Kymera Therapeutics Mentioned together
Financial activity involving secondary offerings and insider buying was observed.
-
Cambridge Shared context
Wave Life Sciences is headquartered in Cambridge, Massachusetts.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
2 eventsAugust 2026
1 eventShow 1 earlier month
June 2026
8 events- Wave Life Sciences established its company headquarters in Cambridge, Massachusetts.
- Wave Life Sciences is seeking the accelerated approval pathway from the FDA ahead of mid-2026 feedback.
- H.C. Wainwright reaffirmed a buy rating on Wave Life Sciences, which also presented preclinical evidence at an ADA meeting in Chicago.
- Both CRISPR Therapeutics and Wave Life Sciences operate within the medical/biomedical industry.
- Wave Life Sciences presented preclinical data at ADA Scientific Sessions on July 15, 2025.
- Wave Life Sciences delivered positive data from the N531 trial, with future milestones and payments remaining uncertain.
- Wave Life Sciences, based in Singapore, is developing therapies for DMD and targeting Huntington’s disease.
- Wells Fargo lowered its price target on September 5, 2025, following trial results related to Wave Life Sciences.